one prior routine of chemotherapy for Innovative breast cancer and through the entire trial, prior publicity to any FGFR inhibitor, big surgery or radiotherapy in 4 months before initial dose of study procedure and getting potent inhibitors or inducers of CYP3A4 or CYP2D6. Any of the following cardiac conditions https://stephenogqbk.bligblogging.com/28535993/azd4547-options